Loading…
Designs, markets and distributes prestige fragrances under licensed brands such as Coach, GUESS, Jimmy Choo and Montblanc.
Designs, markets and distributes prestige fragrances under licensed brands such as Coach, GUESS, Jimmy Choo and Montblanc.
Holds licences for fashion brands rather than owning them: it pays the brand owner a royalty on sales and handles design, outsourced production and distribution, which makes renewal of each licence critical. It operates through a Paris-based arm, separately listed and majority-owned, and a US arm.
Moat: narrow (brand, distribution, IP / patents). Long-term fragrance licenses with global fashion brands and established retail distribution are hard to replicate quickly.
Headquarters: New York, New York, United States · Founded: 1982 · Employees: 662
Size Interparfums (IPAR) is a United States Consumer Staples company (Household/Personal Care) with a market value of $4.34B, the 1294th largest of 3,117 United States companies the cockpit tracks. Shares closed at $135.55 on 6 Nov 2026.
Performance Over six months the shares gained 43.5%, against -5.7% for the median peer and -1.1% for the United States market (cap-weighted) — 4th highest of 21 in its peer set.
Growth Revenue grew 2.9% over the last twelve months (peer median +7.1%); the operating margin is 17.3% (peer median 13.2%).
Valuation It trades at 29.0× forward earnings against a peer median of 18.5× (6th most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is -12 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 6.2 points above its cost of capital (10.1% WACC).
Short interest Short interest is 6.1% of the free float (15 Oct 2026).
Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.50B | $1.49B | $1.45B | $1.32B | $1.09B |
| Revenue growth | — | +2% | +10% | +21% | — |
| Gross profit | $958M | $947M | $927M | $839M | $694M |
| EBITDA | $284M | $296M | $303M | $269M | $222M |
| Net income | $168M | $168M | $164M | $153M | $121M |
| Free cash flow | $246M | $190M | $183M | $99.3M | $81.4M |
| Capital expenditure | $12.8M | $48.2M | $22.4M | $53.4M | $133M |
| Total debt | $165M | $208M | $192M | $192M | $210M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Interparfums IPAR | $4.34B | +43% | +3% | 17% | 29.0× | 10.9% |
| Coty COTY | $3.57B | +64% | -1% | 5% | 13.3× | 11.3% |
| Puig Brands PUIG.MC | $12.5B | +16% | +4% | 16% | 17.9× | -3.0% |
| Interparfums ITP.PA | $3.65B | +72% | -4% | 18% | 27.5× | 15.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | IPAR | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +21.5% | +0.2% | 2nd highest of 21 |
| 6-month return | +43.5% | -5.7% | 4th highest of 21 |
| Distance from 52-week high | -0.7% | -24.1% | highest of 21 |
| Revenue growth (TTM) | +2.9% | +7.1% | 8th lowest of 21 |
| Operating margin | 17.3% | 13.2% | 9th highest of 21 |
| Forward P/E | 29.0× | 18.5× | 6th most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 10.9% | 4.0% | 8th most demanding of 20 |
| Growth delivered (Del g) | +22.5% | +6.6% | 6th highest of 20 |
| Hurdle (Req g minus delivered) | -11.6 pp | -2.8 pp | 7th least demanding of 20 |
| ROIC minus cost of capital | +6.2 pp | +4.8 pp | 9th highest of 20 |
| EV / EBITDA | 15.9× | 14.5× | 8th cheapest of 15 |
| Net debt / EBITDA | -0.2× | -0.8× | 4th most indebted of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Interparfums IPAR | United States | $4.34B | +43% | +3% | 17% | 29.0× | 10.9% | +22.5% |
| Rohto Pharmaceutical 4527.T | Japan | $3.97B | +17% | +10% | 12% | 16.7× | -2.1% | +13.7% |
| Colgate-Palmolive (India) COLPAL.NS | India | $4.83B | -23% | +9% | 28% | 32.2× | 30.8% | +4.5% |
| Cupid CUPID.NS | India | $4.83B | +158% | +122% | 34% | n/a | n/a | n/a |
| Mao Geping Cosmetics 1318.HK | Hong Kong | $4.92B | -28% | +32% | 31% | 15.0× | 4.7% | +41.1% |
| Reynolds Consumer Products REYN | United States | $5.08B | +10% | +2% | 14% | 14.6× | -0.2% | +2.7% |
| Coty COTY | United States | $3.57B | +64% | -1% | 5% | 13.3× | 11.3% | +4.6% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.29B | +20% | +4% | 6% | 50.2× | 17.6% | +1.9% |
| Hengan Int'l 1044.HK | Hong Kong | $3.28B | -16% | +2% | 11% | 9.1× | -8.8% | -0.1% |
| Lion 4912.T | Japan | $3.19B | +21% | +6% | 8% | 19.9× | -2.4% | +3.5% |
| Amorepacific 090430.KS | South Korea | $6.03B | -1% | +10% | 9% | 23.8× | 4.0% | -0.8% |
| Proya Cosmetics 603605.SS | China | $2.97B | -19% | +2% | 13% | 11.1× | -4.8% | +23.1% |
| Giant Biogene 2367.HK | Hong Kong | $2.76B | -34% | -10% | 32% | 9.7× | -8.0% | +34.9% |
| e.l.f. Beauty ELF | United States | $6.85B | +91% | +31% | 12% | 35.4× | 27.9% | +38.8% |
| Winner Medical 300888.SZ | China | $2.69B | -2% | +4% | 11% | 20.9× | -4.3% | -2.6% |
| APR 278470.KS | South Korea | $7.04B | -40% | +119% | 23% | 17.4× | -1.4% | +47.3% |
| Dabur India DABUR.NS | India | $7.13B | -19% | +9% | 15% | 32.1× | 27.3% | +6.6% |
| Gillette India GILLETTE.NS | India | $2.56B | -7% | +8% | 28% | 33.0× | 16.0% | +13.0% |
| LG H&h 051900.KS | South Korea | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% | -4.1% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% | +7.4% |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |